Cross-reactive immunity to clade 2 strains of influenza virus A subtype H5N1 induced in adults and elderly patients by Fluval, a prototype pandemic influenza virus vaccine derived by reverse genetics, formulated with a phosphate adjuvant, and direct
about
A reduced-dose seasonal trivalent influenza vaccine is safe and immunogenic in adult and elderly patients in a randomized controlled trialA single-dose influenza A (H5N1) vaccine safe and immunogenic in adult and elderly patients: an approach to pandemic vaccine developmentH5N1 vaccines in humansAvian influenza pandemic preparedness: developing prepandemic and pandemic vaccines against a moving targetInfluenza A (H5N1) pandemic prototype vaccine Fluval.Refining the approach to vaccines against influenza A viruses with pandemic potential.Preservation of the immunogenicity of dry-powder influenza H5N1 whole inactivated virus vaccine at elevated storage temperatures.An inactivated, adjuvanted whole virion clade 2.2 H5N1 (A/Chicken/Astana/6/05) influenza vaccine is safe and immunogenic in a single dose in humans.Protection of Chinese painted quails (Coturnix chinensis) against a highly pathogenic H5N1 avian influenza virus strain after vaccination.Dose sparing and the lack of a dose-response relationship with an influenza vaccine in adult and elderly patients - a randomized, double-blind clinical trial.
P2860
Q24623902-CE428A3E-1A75-44BF-8DCE-389E1B9F6A5EQ24656615-98CFA00D-DBC9-42C4-8BE7-AA0CC4D3E996Q27000896-88E43957-63C0-4453-9861-DB5B01CC303BQ30227194-80AA1297-0C43-4B16-B3B8-63FB6C92BCB3Q30376553-73B77992-FEB5-4A8E-9277-C6DB32CB5682Q30381595-0DFF7292-14CF-436C-8793-3063F87504B9Q30386212-E71FCAFE-EE14-485C-BB21-7AC82BE8EC83Q37124744-BC685E43-3920-46BC-87F3-0306E47BA585Q37316060-67955B16-63D8-44EA-90FA-1174928BB2B6Q38853908-9C980A99-F563-430B-8E9C-B4A621A7D71F
P2860
Cross-reactive immunity to clade 2 strains of influenza virus A subtype H5N1 induced in adults and elderly patients by Fluval, a prototype pandemic influenza virus vaccine derived by reverse genetics, formulated with a phosphate adjuvant, and direct
description
2008 nî lūn-bûn
@nan
2008 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Cross-reactive immunity to cla ...... phosphate adjuvant, and direct
@ast
Cross-reactive immunity to cla ...... phosphate adjuvant, and direct
@en
type
label
Cross-reactive immunity to cla ...... phosphate adjuvant, and direct
@ast
Cross-reactive immunity to cla ...... phosphate adjuvant, and direct
@en
prefLabel
Cross-reactive immunity to cla ...... phosphate adjuvant, and direct
@ast
Cross-reactive immunity to cla ...... phosphate adjuvant, and direct
@en
P2093
P2860
P356
P1476
Cross-reactive immunity to cla ...... phosphate adjuvant, and direct
@en
P2093
György Fazekas
Istvan Jankovics
Istvan Szilvasy
Rita Martosne-Mendi
Zoltan Vajo
P2860
P304
P356
10.1128/CVI.00327-08
P577
2008-11-19T00:00:00Z